Christopher Pennil

Christopher Pennil

UNVERIFIED PROFILE

Are you Christopher Pennil?   Register this Author

Register author
Christopher Pennil

Christopher Pennil

Publications by authors named "Christopher Pennil"

Are you Christopher Pennil?   Register this Author

11Publications

313Reads

15Profile Views

Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas.

Clin Cancer Res 2014 Feb 15;20(3):764-75. Epub 2013 Nov 15.

Authors' Affiliations: Division of Gynecologic Oncology; Division of Medical Genetics; Departments of Pathology and Laboratory Medicine, University of Washington Medical Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2287DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944197PMC
February 2014

53BP1 expression in sporadic and inherited ovarian carcinoma: Relationship to genetic status and clinical outcomes.

Gynecol Oncol 2013 Mar 12;128(3):493-9. Epub 2012 Dec 12.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle, WA 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.12.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889639PMC
March 2013

Characteristics of women with ovarian carcinoma who have BRCA1 and BRCA2 mutations not identified by clinical testing.

Gynecol Oncol 2013 Mar 19;128(3):483-7. Epub 2012 Dec 19.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Box 356460, University of Washington School of Medicine, Seattle, WA 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.12.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913382PMC
March 2013

BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma.

Cancer 2013 Jan 18;119(2):332-8. Epub 2012 Jul 18.

Division of Gynecologic Oncology, University of Washington Medical Center, Seattle, Washington 98195-6460, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27720DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966566PMC
January 2013

Loss of function germline mutations in RAD51D in women with ovarian carcinoma.

Gynecol Oncol 2012 Dec 14;127(3):552-5. Epub 2012 Sep 14.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle, WA 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.09.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905744PMC
December 2012

Microparticles from ovarian carcinomas are shed into ascites and promote cell migration.

Int J Gynecol Cancer 2012 May;22(4):546-52

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0b013e318241d9b9DOI Listing
May 2012

Secondary somatic mutations restoring BRCA1/2 predict chemotherapy resistance in hereditary ovarian carcinomas.

J Clin Oncol 2011 Aug 27;29(22):3008-15. Epub 2011 Jun 27.

University of Washington Medical Center, Department of Obstetrics and Gynecology, Box 356460, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.34.2980DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3157963PMC
August 2011

Identification of a preneoplastic gene expression profile in tubal epithelium of BRCA1 mutation carriers.

Neoplasia 2010 Dec;12(12):993-1002

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle, WA 98195, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003134PMC
http://dx.doi.org/10.1593/neo.101044DOI Listing
December 2010